Pfizer

Filed a patent for "methods for producing an adjuvant" on Mon, February 20, 2023

Filed a patent for "dosing regimens comprising a kat6 inhibitor for the treatment of cancer" on Wed, May 24, 2023

Filed a patent for "dosing regimens comprising a kat6 inhibitor for the treatment of cancer" on Thu, June 1, 2023

Filed a patent for "deuterated antiviral compounds" on Fri, August 11, 2023

Filed a patent for "display screen or portion thereof with graphical user interface" on Tue, June 27, 2023

Filed a patent for "polynucleotide compositions and uses thereof" on Wed, June 14, 2023

Filed a patent for "health information network wellness platform" on Tue, June 27, 2023

Filed a patent for "compositions and methods for stabilizing rna" on Thu, December 14, 2023

Filed a patent for "polynucleotide compositions and uses thereof" on Mon, May 20, 2024

Filed a patent for "systems and methods for activating a medical testing device with near-field communication" on Wed, April 5, 2023

Filed a patent for "novel 5-cyclopropylquinoline derivatives as plpro inhibitors" on Tue, April 11, 2023

Filed a patent for "cd47 blocking agent and anti-cd20 / anti-cd3 bispecific antibody combination therapy" on Fri, May 12, 2023

Filed a patent for "anti-tl1a antibody therapeutic methods" on Wed, May 17, 2023

Filed a patent for "method of treating breast cancer" on Tue, November 28, 2023

Filed a patent for "anti-tl1a antibody therapeutic methods" on Tue, May 14, 2024

Filed a patent for "glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof" on Fri, April 14, 2023

Filed a patent for "immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof" on Fri, April 14, 2023

Filed a patent for "lilrb1 and lilrb2 antibodies and methods of use thereof" on Wed, April 19, 2023

Filed a patent for "glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof" on Tue, November 14, 2023

Filed a patent for "immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof" on Fri, March 15, 2024

Filed a patent for "pyrido[4,3-d]pyrimidine compounds" on Wed, April 5, 2023

Filed a patent for "ampk-activating compounds and uses thereof" on Thu, April 6, 2023

Filed a patent for "pyrido[4,3-d]pyrimidine compounds" on Mon, June 12, 2023

Filed a patent for "pyrido[4,3-d]pyrimidine compounds" on Fri, September 22, 2023

Filed a patent for "pyrido[4,3-d]pyrimidine compounds" on Tue, November 14, 2023